Atara Biotherapeutics ATRA
NASDAQ ATRA
$9.48 +1.02 (+12.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Cash & Current Investments (2013 - 2026)

Updated

Atara Biotherapeutics' Cash & Current Investments came in at $9.9 million for Q2 2026, down 55.7% from $22.32 million a year earlier but up 17.9% from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Atara Biotherapeutics' Cash & Current Investments was $8.5 million, down 80.0% from FY2024.

  • Cash & Current Investments has declined in each of the last five years, with a five-year compound annual growth rate of -55.7% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $42.5 million in FY2024 (-17.8%), $51.73 million in FY2023 (-78.7%), $242.82 million in FY2022 (-34.6%) and $371.07 million in FY2021 (-25.9%).
  • The five-year range for quarterly Cash & Current Investments is $8.4 million (Q1 2026) to $371.07 million (Q4 2021).
  • Year-over-year, Cash & Current Investments has declined for 19 consecutive quarters, with an average decline of 51.7% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2021 (growth of 9.2%), and the weakest in Q4 2025 (a decline of 80.0%).
  • Business Quant data shows ATRA's Cash & Current Investments at $8.4 million (Q1 2026), $8.5 million (Q4 2025) and $13.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Atara Biotherapeutics 142.51 Mn 132.61 Mn 439,000.00 9.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.90 Mn
Mar 31, 2026 8.40 Mn
Dec 31, 2025 8.50 Mn
Sep 30, 2025 13.71 Mn
Jun 30, 2025 22.32 Mn
Mar 31, 2025 13.84 Mn
Dec 31, 2024 42.50 Mn
Sep 30, 2024 67.19 Mn
Jun 30, 2024 35.29 Mn
Mar 31, 2024 46.24 Mn
Dec 31, 2023 51.73 Mn
Sep 30, 2023 102.41 Mn
Jun 30, 2023 153.64 Mn
Mar 31, 2023 205.41 Mn
Dec 31, 2022 242.82 Mn
Sep 30, 2022 265.40 Mn
Jun 30, 2022 331.31 Mn
Mar 31, 2022 301.81 Mn
Dec 31, 2021 371.07 Mn
Sep 30, 2021 357.25 Mn
API Access

Atara Biotherapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ATRA&period=max&api_key=YOUR_API_KEY